Voxel S.A.
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.
Market Cap & Net Worth: Voxel S.A. (VOX)
Voxel S.A. (WAR:VOX) has a market capitalization of $301.08 Million (zł1.25 Billion) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #16632 globally and #65 in its home market, demonstrating a -4.33% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Voxel S.A.'s stock price zł119.20 by its total outstanding shares 10502600 (10.50 Million).
Voxel S.A. Market Cap History: 2015 to 2026
Voxel S.A.'s market capitalization history from 2015 to 2026. Data shows growth from $37.44 Million to $301.08 Million (24.60% CAGR).
Index Memberships
Voxel S.A. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
mWIG40
MWIG40
|
$22.71 Billion | 0.63% | #30 of 40 |
Weight: Voxel S.A.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Voxel S.A. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Voxel S.A.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.63x
Voxel S.A.'s market cap is 0.63 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
3.30x
Voxel S.A.'s market cap is 3.30 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $37.44 Million | $132.05 Million | $14.34 Million | 0.28x | 2.61x |
| 2016 | $34.84 Million | $120.66 Million | $11.00 Million | 0.29x | 3.17x |
| 2017 | $33.14 Million | $152.16 Million | $19.80 Million | 0.22x | 1.67x |
| 2018 | $45.45 Million | $170.41 Million | $23.37 Million | 0.27x | 1.94x |
| 2019 | $66.62 Million | $211.66 Million | $22.97 Million | 0.31x | 2.90x |
| 2020 | $85.01 Million | $327.64 Million | $33.96 Million | 0.26x | 2.50x |
| 2021 | $99.86 Million | $442.66 Million | $70.55 Million | 0.23x | 1.42x |
| 2022 | $104.21 Million | $414.80 Million | $44.43 Million | 0.25x | 2.35x |
| 2023 | $193.56 Million | $424.18 Million | $74.20 Million | 0.46x | 2.61x |
| 2024 | $318.25 Million | $507.77 Million | $96.45 Million | 0.63x | 3.30x |
Competitor Companies of VOX by Market Capitalization
Companies near Voxel S.A. in the global market cap rankings as of March 18, 2026.
Key companies related to Voxel S.A. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Voxel S.A. Historical Marketcap From 2015 to 2026
Between 2015 and today, Voxel S.A.'s market cap moved from $37.44 Million to $ 301.08 Million, with a yearly change of 24.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł301.08 Million | -0.50% |
| 2025 | zł302.59 Million | -4.92% |
| 2024 | zł318.25 Million | +64.42% |
| 2023 | zł193.56 Million | +85.73% |
| 2022 | zł104.21 Million | +4.36% |
| 2021 | zł99.86 Million | +17.47% |
| 2020 | zł85.01 Million | +27.59% |
| 2019 | zł66.62 Million | +46.59% |
| 2018 | zł45.45 Million | +37.15% |
| 2017 | zł33.14 Million | -4.88% |
| 2016 | zł34.84 Million | -6.94% |
| 2015 | zł37.44 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Voxel S.A. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $301.08 Million USD |
| MoneyControl | $301.08 Million USD |
| MarketWatch | $301.08 Million USD |
| marketcap.company | $301.08 Million USD |
| Reuters | $301.08 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.